ChiCTR2000034535 版本V1.0 版本创建时间2020/07/09 00:00:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000034535 

最近更新日期:

Date of Last Refreshed on:

2020-07-09 00:00:00 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

审核中(三)吞咽大脑皮层精准rTMS对脑卒中后吞咽障碍的疗效研究

Public title:

Repetitive transcranial magnetic stimulation on the swallowing cerebral cortex for treatment of post-stroke dysphagia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Zhi-Yong

Scientific title:

Repetitive transcranial magnetic stimulation on the swallowing cerebral cortex for treatment of post-stroke dysphagia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王志勇 

研究负责人:

王志勇 

Applicant:

Zhi-Yong Wang 

Study leader:

Zhi-Yong Wang 

申请注册联系人电话:

Applicant telephone:

+8613635298857

研究负责人电话:

Study leader's telephone:

+8613635298857

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

438769004@qq.com

研究负责人电子邮件:

Study leader's E-mail:

438769004@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

Zhi-Yong Wang

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市台江区茶中路20号

研究负责人通讯地址:

20

Applicant address:

20 Chazhong Road, Fuzhou

Study leader's address:

20 Chazhong Road, Fuzhou

申请注册联系人邮政编码:

Applicant postcode:

350005

研究负责人邮政编码:

Study leader's postcode:

350005

申请人所在单位:

福建医科大学附属第一医院

Applicant's institution:

The First Affiliated Hospital of Fujian Medical University

研究负责人所在单位:

福建医科大学附属第一医院

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

闽医大附一伦理医研[2020]154号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建医科大学附属第一医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Fujian Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-05-06 00:00:00

伦理委员会联系人:

王柠

Contact Name of the ethic committee:

Ning Wang

伦理委员会联系地址:

福建省福州市台江区茶中路20号

Contact Address of the ethic committee:

20 Chazhong Road, Fuzhou

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建医科大学附属第一医院

Primary sponsor:

The First Affiliated Hospital of Fujian Medical University

研究实施负责(组长)单位地址:

福建省福州市台江区茶中路20号

Primary sponsor's address:

20 Chazhong Road, Fuzhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建医科大学附属第一医院

具体地址:

台江区茶中路20号

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Address:

20 Chazhong Road, Taijiang District

经费或物资来源:

自筹经费

Source(s) of funding:

Self-financing

Target disease:

post-stroke dysphagia

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

探讨重复经颅磁刺激作用于吞咽大脑皮层对脑卒中后吞咽障碍的疗效  

Objectives of Study:

To investigate the effect of repetitive transcranial magnetic stimulation on swallowing cerebral cortex on poststroke dysphagia

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄18-80岁;②病程≤6个月,认知功能正常,吞咽造影视频透视检查提示存在卒中后吞咽障碍, 生命体征平稳;③经患者或家属同意接受此项研究,研究前签订知情同意书。

Inclusion criteria

① Age 18-80 years old; ② Course of disease ≤ 6 months, normal cognitive function, dysphagia was caused by
stroke, confirmed by a videofluoroscopic swallowing study, vital signs are stable; ③ With the consent of the patient or family to accept this study, sign an informed consent before the study .

排除标准:

①生命体征不平稳;②癫痫病史;③既往鼻咽癌放疗、头颈癌及口腔癌术后或其他头颈部结构性病变;④颅内有金属装置;⑤既往有脑出血、蛛网膜下腔出血、脑肿瘤、脑外伤及其他神经精神系统病史;⑥失语;⑦既往有存在吞咽困难等情况。面神经麻痹病史。

Exclusion criteria:

①Vital signs are unstable; ②Historical history of epilepsy; ③Previous postoperative radiotherapy of nasopharyngeal carcinoma, head and neck cancer and oral cancer or other structural changes of head and neck; ④Metal device in the skull; ⑤Previous cerebral hemorrhage and subarachnoid space History of hemorrhage, brain tumor, brain trauma and other neuropsychiatric system; ⑥ aphasia; ⑦ previous dysphagia. A history of facial nerve paralysis.

研究实施时间:

Study execute time:

From 2020-07-08 00:00:00 To 2021-07-08 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-07-08 00:00:00 To 2021-07-08 00:00:00  

干预措施:

Interventions:

组别:

精准rTMS组

样本量:

20

Group:

Precision rTMS group

Sample size:

干预措施:

rTMS精准刺激吞咽大脑皮层

干预措施代码:

Intervention:

Precision rTMS on the swallowing cerebral cortex

Intervention code:

组别:

常规rTMS组

样本量:

20

Group:

Regular rTMS group

Sample size:

干预措施:

rTMS常规刺激吞咽大脑皮层

干预措施代码:

Intervention:

Regular rTMS on the swallowing cerebral cortex

Intervention code:

组别:

假刺激组

样本量:

20

Group:

Sham rTMS group

Sample size:

干预措施:

rTMS假刺激吞咽大脑皮层

干预措施代码:

Intervention:

Sham rTMS on the swallowing cerebral cortex

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China 

Province:

Fujian 

City:

Fuzhou 

单位(医院):

福建医科大学附属第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

功能性吞咽障碍量表

指标类型:

主要指标

Outcome:

the functional dysphagia scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能性经口摄食量表

指标类型:

主要指标

Outcome:

the functional oral intake scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

渗漏-误吸量表

指标类型:

主要指标

Outcome:

the penetration-aspiration scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

符合纳入及排除标准的患者,根据其就诊顺序按随机数字表随机分到各组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients in accordance with the inclusion and exclusion criteria, according to the order of treatment according to the random number table,randomly divided into groups.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

提供给杂志期刊

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Provide thedata to journals

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过病例记录表采集记录数据,建立电子数据库管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collect record data through case record table and establish electronic database management data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-07-09 00:00:00